Literature DB >> 26085469

Severe hepatoxicity caused by aspirin overdose: a case report.

Zhuping Cao1, Shiqi Liu, Jianhua Niu, Bing Wei, Jie Xu.   

Abstract

We report here the rare case of a 61-year-old man with multiple organ dysfunction caused by an aspirin overdose (4 g orally). The patient presented with a fever that reached 39.2 °C, a peptic ulcer, and massive upper gastrointestinal bleeding. His blood test results were as follows: white blood cell count, 1.8 × 10(9)/L; absolute lymphocytes, 0.4 × 10(9)/L; absolute neutrophils, 1.2 × 10(9)/L; and electrolyte disturbances. A computed tomography (CT) scan showed evidence of bilateral inferior pulmonary infection and acute pancreatitis. Thick dark bile with visible floccule was drawn via a percutaneous transhepatic cholangiodrainage (PTCD). Klebsiella pneumoniae was detected in microbiological bile tests. Two years later, the patient died of chronic liver failure.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26085469     DOI: 10.1007/s11684-015-0398-7

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  10 in total

1.  Acetaminophen, aspirin, and renal failure.

Authors:  William Thurlow
Journal:  N Engl J Med       Date:  2002-05-16       Impact factor: 91.245

2.  Acetaminophen, aspirin, and chronic renal failure.

Authors:  C M Fored; E Ejerblad; P Lindblad; J P Fryzek; P W Dickman; L B Signorello; L Lipworth; C G Elinder; W J Blot; J K McLaughlin; M M Zack; O Nyrén
Journal:  N Engl J Med       Date:  2001-12-20       Impact factor: 91.245

3.  A survival case of severe liver failure caused by acetylsalicylic acid that was treated with living donor liver transplantation.

Authors:  S Hagiwara; M Kaneko; M Murata; T Ikegami; K Oshima
Journal:  Hippokratia       Date:  2014-01       Impact factor: 0.471

4.  Aspirin hepatitis associated with encephalopathy.

Authors:  B G Petty; K G Zahka; M T Bernstein
Journal:  J Pediatr       Date:  1978-11       Impact factor: 4.406

5.  Aspirin-induced hepatic encephalopathy and chronic liver disease.

Authors:  A I Lazarovits; G M Robinson; P Devenyi
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391

6.  A case of acute pancreatitis possibly associated with combined salicylate and simvastatin treatment.

Authors:  Stavros Antonopoulos; Sotiris Mikros; Stelios Kokkoris; John Protopsaltis; Konstantina Filioti; Dimitrios Karamanolis; Grigorios Giannoulis
Journal:  JOP       Date:  2005-05-10

7.  Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications.

Authors:  Luis A García Rodríguez; Kueiyu Joshua Lin; Sonia Hernández-Díaz; Saga Johansson
Journal:  Circulation       Date:  2011-02-28       Impact factor: 29.690

8.  Long-term aspirin pretreatment in the prevention of cerulein-induced acute pancreatitis in rats.

Authors:  Ibrahim Akyazi; Evren Eraslan; Ahmet Gülçubuk; Elif Ergül Ekiz; Zeynep L Cırakli; Damla Haktanir; Deniz Aktaran Bala; Mete Ozkurt; Erdal Matur; Mukaddes Ozcan
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

9.  Acetaminophen, aspirin and progression of advanced chronic kidney disease.

Authors:  Marie Evans; Carl Michael Fored; Rino Bellocco; Garrett Fitzmaurice; Jon P Fryzek; Joseph K McLaughlin; Olof Nyrén; Carl-Gustaf Elinder
Journal:  Nephrol Dial Transplant       Date:  2009-01-20       Impact factor: 5.992

10.  [Acute pancreatitis--induced by 5-aminosalicylic acid or an extraintestinal manifestation of ulcerative colitis?].

Authors:  H H Petersen; H Skovbjerg
Journal:  Ugeskr Laeger       Date:  1995-09-25
  10 in total
  1 in total

1.  Next-Generation Noncompetitive Nanosystems Based on Gambogic Acid: In silico Identification of Transferrin Receptor Binding Sites, Regulatory Shelf Stability, and Their Preliminary Safety in Healthy Rodents.

Authors:  M Arora; R Ganugula; N Kumar; G Kaur; J-P Pellois; P Garg; M N V Ravi Kumar
Journal:  ACS Appl Bio Mater       Date:  2019-07-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.